Søren Gullaksen

6PUBLICATIONS
30CO-AUTHORS
Molecular medicineMedical infection agents (incl. prions)Wastewater treatment processesMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 14, 2025
Colchicine mitigates arterial stiffness in high-risk patients with type 2 diabetes: a randomized placebo-controlled trial.

Jonathan M Baier, Kristian L Funck, Liv Vernstrøm

|Jul 30, 2024
Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.

Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen

|May 13, 2024
Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.

Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen

|Dec 28, 2023
Metabolic Communication by SGLT2 Inhibition.

Anja M Billing, Young Chul Kim, Søren Gullaksen

|Feb 06, 2023
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.

Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen

|Feb 05, 2019
Volumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls.

Søren Gullaksen, Kristian Løkke Funck, Esben Laugesen

Pageof 1

Frequent Collaborators

5 joint publications

Kristian Løkke Funck

5 joint publications

Esben Laugesen

4 joint publications

Liv Vernstrøm

4 joint publications

Per L Poulsen